Panel Presentation Will Feature Top Medical Device Experts from Aperio Clinical Outcomes, JD Lymon Group, Brooks Medtech, LLC, and NuPulseCV, Inc.
Aperio Clinical Outcomes, a clinical development organization headquartered in Morrisville, NC, will moderate a panel presentation titled “Begin With the End in Mind: Preparing for Your Medical Device Clinical Trial” at LaunchBio, Inc. on Thursday, November 7, 2019.
Whether it is to support a Premarket Approval (PMA), 510(k), or post-market strategies, your clinical trial is a crucial next step in the life of your medical device. Understanding the multiple facets necessary to consider in the clinical development process will provide you with a holistic view of the road ahead, and allow for realistic short- and long-term planning for your device development and commercialization.
Join our presentation and hear from a panel of industry experts in medtech development as we discuss what to keep in mind when moving towards a medical device clinical trial, including:
- Regulatory pathways
- Reimbursement planning
- Study design considerations
- Operationalizing your clinical trial
The panel is scheduled to take place from 4:15 – 5:15 pm at the Chesterfield Building in downtown Durham and will include a Q&A time with the panelists and ample networking opportunities afterward in the main room. Cari Kniola, Director of Corporate Strategy at Aperio Clinical Outcomes, will moderate our distinguished line-up of panelists:
Chris Lyle, MS
JD Lymon Group
Steven Brooks, MD, MBA, FACC
Brooks Medtech, LLC
Sonna Patel-Raman, PhD
LaunchBio takes place from 4:00 – 7:00 pm at The Chesterfield in downtown Durham. Aperio’s panel is scheduled for 4:15 – 5:15 pm.
To learn more or to register to attend LaunchBio, click here.